Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Vantari Genetics | RCV000210773 | SCV000267036 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-11 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224428 | SCV000280899 | likely benign | not provided | 2015-08-17 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV000228558 | SCV000288843 | benign | Xeroderma pigmentosum, group F; Cockayne syndrome; Fanconi anemia complementation group Q | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000116989 | SCV000310925 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001117767 | SCV001275987 | benign | Xeroderma pigmentosum, group F | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000224428 | SCV001901105 | benign | not provided | 2019-04-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28051113, 17419091, 24728327, 20061190, 22374244, 15886521, 10479728, 24465539, 18767034, 28690523, 19626602, 24704021, 24004570) |
KCCC/NGS Laboratory, |
RCV001117767 | SCV004017486 | benign | Xeroderma pigmentosum, group F | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000224428 | SCV005217485 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000116989 | SCV000084972 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Genetic Services Laboratory, |
RCV000116989 | SCV000151110 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Genome Diagnostics Laboratory, |
RCV000116989 | SCV002035124 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224428 | SCV002036127 | likely benign | not provided | no assertion criteria provided | clinical testing |